Year |
Citation |
Score |
2013 |
Koh YT, Scatizzi JC, Gahan JD, Lawson BR, Baccala R, Pollard KM, Beutler BA, Theofilopoulos AN, Kono DH. Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells. Journal of Immunology (Baltimore, Md. : 1950). 190: 4982-90. PMID 23589617 DOI: 10.4049/Jimmunol.1202986 |
0.328 |
|
2012 |
Rivas MN, Koh YT, Chen A, Nguyen A, Lee YH, Lawson G, Chatila TA. MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. The Journal of Clinical Investigation. 122: 1933-47. PMID 22466646 DOI: 10.1172/Jci40591 |
0.403 |
|
2010 |
Theofilopoulos AN, Gonzalez-Quintial R, Lawson BR, Koh YT, Stern ME, Kono DH, Beutler B, Baccala R. Sensors of the innate immune system: their link to rheumatic diseases. Nature Reviews. Rheumatology. 6: 146-56. PMID 20142813 DOI: 10.1038/Nrrheum.2009.278 |
0.356 |
|
2009 |
Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, Arnold CN, Baccala R, Silverman GJ, Beutler BA, Theofilopoulos AN. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proceedings of the National Academy of Sciences of the United States of America. 106: 12061-6. PMID 19574451 DOI: 10.1073/Pnas.0905441106 |
0.341 |
|
2009 |
Koh YT, Gray A, Higgins SA, Hubby B, Kast WM. Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. The Prostate. 69: 571-84. PMID 19143030 DOI: 10.1002/Pros.20906 |
0.442 |
|
2006 |
Koh YT, Higgins SA, Weber JS, Kast WM. Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant. Journal of Translational Medicine. 4: 42. PMID 17059610 DOI: 10.1186/1479-5876-4-42 |
0.445 |
|
2005 |
Vatakis DN, Koh YT, McMillan M. CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines. Vaccine. 23: 2639-46. PMID 15780447 DOI: 10.1016/J.Vaccine.2004.10.039 |
0.424 |
|
Show low-probability matches. |